electroCore to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
electroCore (Nasdaq: ECOR), a bioelectronic medicine and wellness company, has announced its participation in the 26th Annual H.C. Wainwright Global Investment Conference in New York City from September 9-11, 2024. The company's CEO, Dan Goldberger, will take part in a fireside chat on Wednesday, September 11th, at 12:00 PM ET.
This event provides an opportunity for investors to gain insights into electroCore's operations and future plans. Mr. Goldberger will also be available for one-on-one meetings on the same day, offering a chance for more in-depth discussions with interested parties. The conference serves as a platform for electroCore to showcase its advancements in the field of bioelectronic medicine and wellness to a global investment audience.
electroCore (Nasdaq: ECOR), un'azienda di medicina bioelettronica e benessere, ha annunciato la sua partecipazione al 26° Annual H.C. Wainwright Global Investment Conference a New York City dal 9 all'11 settembre 2024. Il CEO dell'azienda, Dan Goldberger, parteciperà a una chat informale mercoledì 11 settembre, alle 12:00 PM ET.
Questo evento offre un'opportunità agli investitori per ottenere informazioni sulle operazioni e i piani futuri di electroCore. Il signor Goldberger sarà inoltre disponibile per incontri individuali lo stesso giorno, offrendo la possibilità di discussioni più approfondite con le parti interessate. La conferenza funge da piattaforma per electroCore per mettere in mostra i suoi progressi nel campo della medicina bioelettronica e del benessere a un pubblico globale di investitori.
electroCore (Nasdaq: ECOR), una empresa de medicina bioelectrónica y bienestar, ha anunciado su participación en la 26ª Conferencia Anual Global de Inversión H.C. Wainwright en Nueva York del 9 al 11 de septiembre de 2024. El CEO de la compañía, Dan Goldberger, participará en una charla informal el miércoles 11 de septiembre a las 12:00 PM ET.
Este evento brinda una oportunidad a los inversores para obtener información sobre las operaciones y los planes futuros de electroCore. El Sr. Goldberger también estará disponible para reuniones individuales ese mismo día, ofreciendo la posibilidad de discusiones más profundas con los interesados. La conferencia sirve como una plataforma para que electroCore muestre sus avances en el campo de la medicina bioelectrónica y el bienestar a una audiencia global de inversores.
electroCore (Nasdaq: ECOR)는 생체 전자 의학 및 웰니스 회사로, 2024년 9월 9일부터 11일까지 뉴욕에서 열리는 제26회 H.C. Wainwright 글로벌 투자 컨퍼런스에 참여한다고 발표했습니다. 회사의 CEO인 Dan Goldberger는 9월 11일 수요일 오후 12시 ET에 진행되는 파이어사이드 채팅에 참석할 예정입니다.
이번 행사는 투자자들이 electroCore의 운영 및 미래 계획에 대한 통찰력을 얻을 수 있는 기회를 제공합니다. Goldberger 씨는 같은 날 1대1 미팅에 참석하여 관심 있는 당사자들과 심층 토론을 할 수 있도록 할 것입니다. 이번 컨퍼런스는 electroCore가 생체 전자 의학 및 웰니스 분야에서의 발전을 전 세계 투자자들에게 소개하는 플랫폼 역할을 합니다.
electroCore (Nasdaq: ECOR), une entreprise de médecine bioélectronique et de bien-être, a annoncé sa participation à la 26ème Conférence annuelle H.C. Wainwright sur les investissements mondiaux à New York du 9 au 11 septembre 2024. Le PDG de l'entreprise, Dan Goldberger, participera à une discussion informelle le mercredi 11 septembre à 12h00 ET.
Cette événement offre aux investisseurs l'opportunité d'obtenir des informations sur les opérations et les projets futurs d'electroCore. M. Goldberger sera également disponible pour des réunions individuelles le même jour, offrant la possibilité de discussions plus approfondies avec les parties intéressées. La conférence sert de plateforme à electroCore pour présenter ses avancées dans le domaine de la médecine bioélectronique et du bien-être à un public mondial d'investisseurs.
electroCore (Nasdaq: ECOR), ein Unternehmen für bioelektronische Medizin und Wellness, hat seine Teilnahme an der 26. jährlichen H.C. Wainwright Global Investment Conference in New York City vom 9. bis 11. September 2024 angekündigt. Der CEO des Unternehmens, Dan Goldberger, wird am Mittwoch, den 11. September um 12:00 Uhr ET an einem Fireside-Chat teilnehmen.
Diese Veranstaltung bietet Investoren die Möglichkeit, Einblicke in die Abläufe und zukünftigen Pläne von electroCore zu gewinnen. Herr Goldberger wird an diesem Tag auch für Einzelgespräche zur Verfügung stehen, um interessierten Parteien die Möglichkeit zu bieten, tiefere Diskussionen zu führen. Die Konferenz dient als Plattform für electroCore, um die Fortschritte im Bereich der bioelektronischen Medizin und Wellness einem globalen Investorenpublikum vorzustellen.
- None.
- None.
ROCKAWAY, N.J., Sept. 04, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will be participating in the 26th Annual H.C. Wainwright Global Investment Conference taking place in New York City on September 9-11, 2024.
Dan Goldberger, the company’s Chief Executive Officer, will participate in a fireside chat on Wednesday, September 11th, at 12:00 PM ET. Mr. Goldberger will also be available for 1x1 meetings the same day.
For more information regarding the conference and to register, please visit the conference page here.
About electroCore, Inc.
electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company dedicated to improving health through its non-invasive vagus nerve stimulation (“nVNS”) technology platform. Our focus is the commercialization of medical devices for the management and treatment of certain medical conditions and consumer product offerings utilizing nVNS to promote general wellbeing and human performance in the United States and select overseas markets.
For more information, visit www.electrocore.com.
Forward-Looking Statements
This press release and other written and oral statements made by representatives of electroCore may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, but are not limited to, statements about electroCore's business prospects and clinical and product development plans (including with respect to ongoing studies); its pipeline or potential markets for its technologies; the timing, outcome and impact of regulatory, clinical and commercial developments; the issuance of U.S. and international patents providing expanded IP coverage; the possibility of future business models and revenue streams from the company’s potential use of nVNS for rare TAC’s in general and SUNCT/SUNA in particular, the potential of nVNS generally and gammaCore in particular and other statements that are not historical in nature, particularly those that utilize terminology such as "anticipates," "will," "expects," "believes," "intends," other words of similar meaning, derivations of such words and the use of future dates. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the ability to raise the additional funding needed to continue to pursue electroCore’s business and product development plans, the inherent uncertainties associated with developing new products or technologies, the ability to commercialize gammaCore™, the potential impact and effects of COVID-19 on the business of electroCore, electroCore’s results of operations and financial performance, and any measures electroCore has and may take in response to COVID-19 and any expectations electroCore may have with respect thereto, competition in the industry in which electroCore operates and overall market conditions. Any forward-looking statements are made as of the date of this press release, and electroCore assumes no obligation to update the forward-looking statements or to update the reasons why actual results could differ from those projected in the forward-looking statements, except as required by law. Investors should consult all of the information set forth herein and should also refer to the risk factor disclosure set forth in the reports and other documents electroCore files with the SEC available at www.sec.gov.
Contact:
ECOR Investor Relations
(973) 302-9253
investors@electrocore.com
FAQ
When is electroCore (ECOR) participating in the H.C. Wainwright Global Investment Conference?
What is the date and time of Dan Goldberger's fireside chat at the H.C. Wainwright conference?
Will electroCore (ECOR) be offering one-on-one meetings during the H.C. Wainwright conference?
What type of company is electroCore (ECOR)?
